Measuring levels of protein sLR11 in the blood could be useful in testing for pulmonary hypertension (PH) in people…
Articles by Marisa Wexler, MS
The use of imaging to evaluate the right side of the heart could be useful for non-invasively diagnosing and monitoring…
In addition to lowering blood pressure, treatments for pulmonary arterial hypertension (PAH) probably work at least in part by…
People with pulmonary hypertension are at increased risk of developing cancer, especially lung and skin cancers, a new study…
Tenax Therapeutics has completed a pharmacological assessment of TNX-201, the company’s new oral formulation of imatinib for pulmonary arterial…
Pulmonary Hypertension News brought you the latest coverage of advances in treatment, clinical trials, and scientific research related to…
Care at a specialty center is tied to a lower risk of hospitalization for people with heart failure with preserved ejection fraction…
Children with pulmonary arterial hypertension (PAH) report poorer health-related quality of life (HRQoL) than their peers, a study shows.
Aerovate Therapeutics is starting a Phase 2b/3 clinical trial that will test AV-101, the company’s experimental inhaled formulation of imatinib,…
Beyond Air has announced that it is not expecting the U.S. Food and Drug Administration (FDA) to approve its …
Treatment with the experimental medication KER-012 helped to prevent heart damage in a mouse model of pulmonary hypertension,…
By analyzing how medications affect the genetic activity of cells, researchers developed a computational pipeline that may be useful in…